DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

NxStage Medical (NASDAQ: NXTM)

13.40 -0.57 (-4.08%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NXTM $13.40 -4.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.00
Previous Close $13.97
Daily Range $13.35 - $14.00
52-Week Range $8.77 - $15.50
Market Cap $828.5M
P/E Ratio -37.76
Dividend (Yield) $0.00 (0.0%)
Volume 368,623
Average Daily Volume 278,928
Current FY EPS -$0.44

Sector

Healthcare

Industry

Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website: http://www.nxstage.com/

News & Commentary Rss Feed

Is It Time to Buy These 4 Dialysis Stocks?

Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?

Update: NxStage Medical Earnings

NxStage Medical's (NXTM) CEO Jeff Burbank on Q2 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health-Care Shares Higher Pre-Market

NxStage Medical (NXTM) Q2 2014 Results - Earnings Call Webcast

Mariel Therapeutics Acquires Stryker Assets - Analyst Blog

St. Jude Medical Hits New Lifetime High - Analyst Blog

Medtronic's MiniMed Insulin Pump: A Key to Type 2 Diabetes Cure - Analyst Blog

Abaxis' VetScan Test Kit Wins USDA Approval - Analyst Blog

3 Stocks Pushing The Health Services Industry Lower

See More NXTM News...

NXTM's Top Competitors

NXTM $13.40 (-4.08%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $66.22 (-0.47%)
Current stock: MDT
COV $90.85 (-0.82%)
Current stock: COV